📊 Score Breakdown
Offering Ability
90
Cash Runway
95
Float Risk
100
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
64%
💰 Capital Raise
75%
• Critical: only 0.6 months cash remaining
• Active shelf registration ($300M, 1502% of market cap)
🔁 Convertible Conversion
60%
• Major convertible overhang: 55% potential dilution
• Convertible risk score very high (85/100)
🔄 Reverse Split
45%
• 50-day avg $1.12 approaching $1 threshold
• Only 1 months cash — financial pressure
💹 Market Data
Market Cap$19.97M
Shares Outstanding41.48M
Float1.93M
Cash$766.8K
Debt$3.24M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 42.6% shares (2025Q4 vs prior)
2 institutional holders · 12.5K shares
#1
XTX Topco Ltd
10.7K shares
#2
UBS Group AG
1.7K shares
📉 Short Interest
Short Interest11.1K
Days to Cover1.0
% of Float0.6%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Sep 30, 2025
xbrl
XBRL CONVERTIBLE
Sep 30, 2025
6-K
8K EVENT
Apr 01, 2026
6-K
8K EVENT
Mar 26, 2026
3
FORM3
Mar 18, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for LGCB
📊 LGCB FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 LGCB Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.